Qapel

Q'Apel Medical is a neurovascular medical device company based in Fremont, California, founded in 2015.

The company focuses on designing and commercializing innovative access device technology for neurovascular interventions, particularly in stroke treatment. The name Q'Apel is inspired by the Qu'Appelle River in Canada, symbolizing the navigational capabilities of their products through complex brain vasculature. The product lineup includes the Walrus Balloon Guide Catheter, which is used in mechanical thrombectomy procedures for acute ischemic stroke, and has successfully treated over 20,000 patients since its introduction in 2019. Additionally, the Wahoo Hybrid Access System and the Armadillo Radial Access System are part of their offerings. All products utilize SelectFlexTM technology, allowing for flexible and supportive catheter configurations during procedures. Q'Apel Medical's solutions are currently employed in over 200 hospital systems across the United States and have received CE Mark certification for European markets. The company has a workforce of 51-200 employees and has raised $22.1 million in funding.